Effectiveness of medicated nasal drops in headeche

A Randomized controlled clinical study to evaluate The Efficacy of Goghritamandanasya with Sharkarayukta Narikelajalanasya in the management of Ardhavabhedaka

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020224

Enrollment

Registered

2019-07-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache

Interventions

Intervention1: Goghritmanda: Vilinighrita means the ghrita which is completely settled, so the supernant/upper layer of ghrita which is above the ghanibhutabhaga(thickened part) is known as ghritaman

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients showing classical lakshnas of Ardhavabhedak (Ardhashirshula, Bhrama, Prakashasahatva, Shiropatateev(Lightheadness), Hrullas) will be selected for the study. 2) Patients of age group above 25 yrs. and below 60 yrs. 3) Patients will be selected irrespective of gender ,age, religion, occupation, economic and educational status. 4) Willing and able to participate in the study 5) Clinical history of patients will be taken in special prepared case sheet Performa.

Exclusion criteria

Exclusion criteria: 1. Known case of Ardhavabhedaka who is taking other treatment will be excluded. 2. Known case of Hypertension, COPD and other chronic disease. 3. Known case of secondary headaches like meningitis, brain tumor, encephalitis, cervical Spondylitis, refractive errors & glaucoma, Head injury 4. Known case of sinusitis will be excluded from study. 5. Nasya anarha people will be excluded from study. 6. Patients who are incapacitated, bedridden or confined to a wheelchair. 7. Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants, anticholinergics etc. or any other drugs that may have an influence on the outcome of the study.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Goghritmand Nasya and Sharkarayukta Narikelajalanasya in the management of ArdhavabhedakaTimepoint: 30 days with follow up on 8th,15th, 22th, 29th day with window period of 5 days	—

Secondary

Measure	Time frame
To observe any adverse events found if any during the study.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Gayatri Rokade

PDEAs College of Ayurveda and Research center

manishapingale999@yahoo.in9850160353

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026